ReviewHeliyon2025
A review on surface modification of nanofibrous textiles for diverse applications: Focus on medical uses.
Review in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Composite Hydrogels with Embedded Electrospun Fibers as Drug Delivery Systems.Gels (Basel, Switzerland) · 2025Review
Corrections and comments
- Retraction · 2026-01-13Concerns/Issues about Referencing/Attributions · Investigation by Journal/Publisher · Objections by Author(s) · Unreliable Results and/or Conclusions ·
- Retracted
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electrospun nanofibers with a high surface area are attractive materials for biomedical applications. They have potential use in scaffolds, drug delivery, bio face masks, wound dressings, and biosensors. Various surface modifications have been developed to improve their chemical and physical properties. These modifications include physical, chemical, biological, and nano-treatment approaches. The physical modification includes annealing, stretching, and plasma treatment. Chemical modification includes functionalization with chemical groups, while biological modification involves coating with proteins, enzymes, or antibodies. Nanotreatment approaches use nanomaterials to modify the surface of nanofibers. These modifications enhance the characteristics of the biomedical nanofibers, making them more effective and efficient for their intended applications. The review summarizes the latest research on electrospun nanofiber modification procedures, strategies, and utilities for various biomedical applications. It provides insights into the conditions and requirements of each modification approach and their effects on the properties of the nanofibers. Moreover, it emphasizes the importance of functionalizing nanofibers to meet the most important specific requirements and the potential of electrospun nanofibers in various biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.